Further studies are warranted to confirm whether this reduced cancer risk is solely associated with these site-specific cancers or whether it affects all cancers through interruption of the angiogenesis of tumor cells by AT1R antagonists and the antitumor effects of AT2R stimulation [33]. This evidence concerns the gene AGTR1 and neoplasm.